Skip to main content

Month: April 2022

AnPac Bio Appoints Dr. Aidong Chen as New Chief Executive Officer and Chairman of the Board and Miss Sheng Liu as a New Board Member

PHILADELPHIA, April 08, 2022 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that Dr. Aidong Chen has joined the Company as its board director, Chief Executive Officer and Chairman of the Board of Directors. Dr. Aidong Chen has been a practicing physician and researcher for over 10 years. He has received over 20 global patents on his work and published 91 papers over his career. Dr. Chen has been affiliated with many leading hospitals, including Yijishan Hospital, and Nanjing Medical University. He has replaced Dr. Chris Yu, Company’s founder, who resigned as board director, CEO and Chairman of the Board of the Company. As head of China operations of...

Continue reading

Junshi Biosciences and Coherus Present Results of Phase 3 Study of Toripalimab in First Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma at 2022 AACR Annual Meeting

– Toripalimab plus chemotherapy provided superior progression free survival, overall survival, overall response rate and duration of response compared to chemotherapy alone – SHANGHAI, China, and REDWOOD CITY, Calif., April 09, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”) announced the results of the prespecified final progression-free survival (“PFS”) analysis and the interim overall survival (“OS”) analysis of the JUPITER-02 study (NCT03581786), a pivotal Phase 3 trial in first-line treatment of recurrent or metastatic nasopharyngeal carcinoma (“NPC”). The JUPITER-02 results are summarized in a poster presentation at the annual meeting of the American Association for Cancer Research (“AACR”). In the final PFS...

Continue reading

FluroTech Provides Operational Update: Announces Pause on Further Development of its Pandemic and Emerging Disease Defense Platform

CALGARY, Alberta, April 08, 2022 (GLOBE NEWSWIRE) — FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (the “Company” or “FluroTech”), announces that it has decided to pause any further expenditures on development of its Pandemic and Emerging Disease Defense Platform (“PEDDP”), initially targeting COVID-19, until it is able to obtain further financing. While management continues to believe that its COVID-19 testing technology will be viable and needed, the Company will require additional financing to complete the technology through to regulatory approvals in order to become commercial. To that end, management continues to pursue financing options. Readers are cautioned that, although the Company has achieved proof of concept prototype, the testing method and device is still in the pre-approval stage and accordingly the Company is not currently...

Continue reading

Pueblo Viejo Moves Forward with Life of Mine Extension Project

All amounts expressed in US dollars TORONTO, April 08, 2022 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) announced today that the Dominican Government had completed its strategic review of the location of the new Tailings Storage Facility (TSF) for the Pueblo Viejo mine. The new TSF forms part of the expansion project that is designed to extend the Tier One1 mine’s life to beyond 2040 and support annual production in excess of 800,000 ounces2. The Government, through their process, have identified a select number of alternatives for further assessment. At the same time, Barrick conducted its own alternatives assessment, completed by a multi-disciplinary team of external subject matter experts from various independent consulting companies. Several sites were initially identified and after various screening phases,...

Continue reading

Labrador Uranium Provides Update on the Moran Lake Option Agreement

TORONTO, April 08, 2022 (GLOBE NEWSWIRE) — Labrador Uranium Inc. (“LUR” or “Labrador Uranium”) (CSE: LUR) (F: EI1) is providing an update on the option agreement (the “Option Agreement”) which LUR assumed in connection with the acquisition of the Moran Lake Project in Labrador (the “Moran Lake Project”) that was completed on February 22, 2022 pursuant to the spin-out transaction involving Labrador Uranium and Consolidated Uranium. Under the terms of the Option Agreement, the original vendor of the Moran Lake Project (the “Vendor”) is entitled to receive certain payments contingent upon the attainment of certain milestones tied to the spot price of uranium. As the uranium month-end spot price for March exceeded USD$50/lb (the “Pricing Threshold”), the Vendor is entitled to receive payment of an additional CAD$250,000 in cash and...

Continue reading

GFG Announces Management Change

SASKATOON, Saskatchewan, April 08, 2022 (GLOBE NEWSWIRE) — GFG Resources Inc. (TSXV: GFG) (OTCQB: GFGSF) (“GFG” or the “Company”) announces that Mr. Rob Mackie, Vice President of Exploration, has resigned to pursue another opportunity. The Company has commenced a search for a new Vice President of Exploration. The current drill and exploration programs will not be disrupted, and the technical team will report to the CEO until the role is filled. Brian Skanderbeg, President and CEO of GFG, commented, “On behalf of the GFG team and Board, I would like to acknowledge and thank Rob for his significant contributions over the past four years. Under his leadership, GFG has built a very strong exploration team, consolidated a highly prospective regional land position and developed a successful targeting framework; we wish him the very...

Continue reading

REVISED – TransUnion Observes Travel and Leisure Industry Fastest Growing Target for Fraudsters in Canada

TransUnion study reveals the rate of suspected digital fraud attempts across industries coming from Canada increased 21% from 2020 to 2021Suspected digital fraud attempt rate from Canada increased 88% from 2019 to 2021 Nearly four in 10 (40%) Canadians stated they have been targeted by a digital fraud from Oct. 2021 to Jan. 2022 43% of Canadians stated they conduct the majority of their transactions online Concerns about fraud is one of the top reasons Canadians say they abandon online shopping carts (41%) The suspected digital fraud rate for transactions coming from Canada in the travel and leisure industry increased 116% from 2020 to 2021 The suspected digital fraud rate for transactions coming from Canada in gaming and financial services increased 85% and 74% from 2020 to 2021, respectivelyTORONTO, April 08, 2022 (GLOBE NEWSWIRE)...

Continue reading

Notice to Current Beyond Meat Stockholders of Proposed Settlement and Dismissal with Prejudice of Derivative Actions

EL SEGUNDO, Calif., April 08, 2022 (GLOBE NEWSWIRE) — The following is being released by Beyond Meat, Inc. (NASDAQ: BYND) pursuant to an Order of the United States District Court for the Central District of California. IN THE UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF CALIFORNIAIN RE: BEYOND MEAT, INC. DERIVATIVE LITIGATIONCase No.: CV-20-2524-MWF (AFMx)This Document Relates to:  ALL ACTIONS NOTICE TO CURRENT BEYOND MEAT STOCKHOLDERS OF PROPOSED SETTLEMENT AND DISMISSAL WITH PREJUDICE OF DERIVATIVE ACTIONS TO:         ALL RECORD HOLDERS AND BENEFICIAL OWNERS OF THE BEYOND MEAT, INC. (“BEYOND MEAT” OR THE “COMPANY”) COMMON STOCK (TICKER SYMBOL: BYND) AS OF JANUARY 14, 2022. PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY. THIS NOTICE RELATES TO A PROPOSED SETTLEMENT AND DISMISSAL WITH PREJUDICE OF STOCKHOLDER...

Continue reading

FutureFuel to Release First Quarter 2022 Financial Results on May 9, 2022

CLAYTON, Mo., April 08, 2022 (GLOBE NEWSWIRE) — FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, announced today that it will release its first quarter 2022 financial results after market close on Monday, May 9, 2022. About FutureFuel FutureFuel is a leading manufacturer of diversified chemical products, specialty chemical products, and biofuel products. In its chemicals business, FutureFuel manufactures specialty chemicals for specific customers (“custom chemicals”) as well as multi-customer specialty chemicals (“performance chemicals”). FutureFuel’s custom chemicals product portfolio includes proprietary intermediates for major chemical companies and chlorinated polyolefin adhesion promoters and antioxidant precursors for a major chemical company. FutureFuel’s performance...

Continue reading

Itaú Corpbanca Schedules First Quarter 2022 Financial Results, Conference Call and Webcast

SANTIAGO, Chile, April 08, 2022 (GLOBE NEWSWIRE) — ITAÚ CORPBANCA (NYSE: ITCB; SSE: ITAUCORP) announced today that it will release its results for the first quarter ended March 31, 2022, before the market opens in Santiago and in New York on Friday, April 29, 2022. On Monday, May 2, 2022, at 11:00 A.M. Santiago time (11:00 A.M. ET), the Company’s management team will host a conference call to discuss the financial results. The call will be hosted by Gabriel Moura, Itaú Corpbanca’s Chief Executive Officer, Rodrigo Couto, Itaú Corpbanca’s Chief Financial Officer and Claudia Labbé, Itaú Corpbanca’s Head of Investor Relations. Conference Call Details: Online registration: https://conferencingportals.com/event/LcAnNmZD Phone registration: +1 (800) 770-2030 or +1 (647) 362-9199 International Dial-ins: https://events.q4irportal.com/custom/access/2324/ Upon...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.